Target Price | $674.69 |
Price | $541.93 |
Potential | 24.50% |
Number of Estimates | 13 |
13 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $674.69. This is 24.50% higher than the current stock price. The highest price target is $800.00 47.62% , the lowest is $585.00 7.95% . | |
A rating was issued by 18 analysts: 15 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 24.50% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
13 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.6b . This is 25.66% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.7b 28.32% , the lowest is $2.6b 23.65% .
This results in the following potential growth metrics:
2024 | $2.1b | 33.44% |
---|---|---|
2025 | $2.6b | 25.76% |
2026 | $3.2b | 22.43% |
2027 | $3.7b | 14.77% |
13 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $659m . This is 515.06% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $672m 526.78% , the lowest is $644m 501.07% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $112m | 37.53% |
---|---|---|
2025 | $659m | 490.49% |
2026 | $829m | 25.72% |
2027 | $1.0b | 21.85% |
2024 | 5.36% | 53.19% |
---|---|---|
2025 | 25.18% | 369.58% |
2026 | 25.85% | 2.66% |
2027 | 27.45% | 6.19% |
8 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $24.3m . This is 93.36% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $217m 40.80% , the lowest is $-40.6m 111.09% .
This results in the following potential growth metrics and future Net Margins:
2024 | $368m | 106.01% |
---|---|---|
2025 | $24.3m | 93.38% |
2026 | $184m | 654.46% |
2024 | 17.66% | 54.39% |
---|---|---|
2025 | 0.93% | 94.73% |
2026 | 5.72% | 515.05% |
8 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $0.32 . This is 93.31% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.83 40.79% , the lowest is $-0.53 111.09% .
This results in the following potential growth metrics and future valuations:
2024 | $4.80 | 106.01% |
---|---|---|
2025 | $0.32 | 93.33% |
2026 | $2.40 | 650.00% |
Current | 117.09 | 13.09% |
---|---|---|
2025 | 1,762.30 | 1,405.08% |
2026 | 233.55 | 86.75% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 16.26 and an P/S ratio of 16.37 .
This results in the following potential growth metrics and future valuations:
Current | 20.44 | 39.90% |
---|---|---|
2025 | 16.26 | 20.43% |
2026 | 13.28 | 18.32% |
2027 | 11.58 | 12.87% |
Current | 20.57 | 37.11% |
---|---|---|
2025 | 16.37 | 20.42% |
2026 | 13.37 | 18.32% |
2027 | 11.65 | 12.87% |
Axon Enterprise Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 27 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Feb 26 2025 |
Citizens Capital Markets |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 26 2025 |
Craig-Hallum |
Buy
➜
Hold
|
Downgrade | Feb 20 2025 |
JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 04 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jan 27 2025 |
TD Cowen |
➜
Buy
|
Initiated | Jan 08 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 27 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Feb 26 2025 |
Unchanged
Citizens Capital Markets:
Market Outperform
➜
Market Outperform
|
Feb 26 2025 |
Downgrade
Craig-Hallum:
Buy
➜
Hold
|
Feb 20 2025 |
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Feb 04 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jan 27 2025 |
Initiated
TD Cowen:
➜
Buy
|
Jan 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.